跳至主要内容
临床试验/NCT05117307
NCT05117307尚未招募不适用

Comparison of Transversalis Fascia Plane Block and Erector Spinae Plane Blocks in Cesarean Section

Erzurum Regional Training & Research Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年12月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Opioid Consumption

研究概览

简要总结

Cesarean section is one of the most common major surgical procedures performed worldwide,, Post-cesarean analgesia should provide adequate pain control while allowing the mother to remain active to meet the needs of the baby. Insufficient analgesia after cesarean section may be associated with acute postoperative pain, chronic pain, higher opioid consumption, delayed functional capacity, and postpartum depression. Techniques such as neuraxial techniques, oral and intravenous agents, wound infiltration, and behavioral therapy can be used in the treatment of post-cesarean pain pain. In addition, Transversus abdominis plane block (TAP), Quadratus Lumborum block (QLB), Erector Spina block (ESP), Transversalis Fascia plane block (TFP) are used safely under ultrasound guidance. In this study, it was aimed primarily to examine the effects of TFP and ESP blocks on pain scores, and secondarily to evaluate analgesic consumption.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Between 18-50 years
  • Cesarean Section

排除标准

  • Cesarean Section under general anesthesia
  • emergency cases
  • those with a body mass index greater than 35 kg/m2
  • coagulopathy
  • local infection

研究组 & 干预措施

Group ESP

Active Comparator

Ultrasound-guided erector spinae plane block with 20 ml %0.25 bupivacaine, per side

干预措施: Bupivacaine 0.25% Injectable Solution (Drug)

Group TFP

Active Comparator

Ultrasound-guided Transversalis Fascia Plane Block block with 20 ml %0.25 bupivacaine, per side

干预措施: Bupivacaine 0.25% Injectable Solution (Drug)

结局指标

主要结局

Opioid Consumption

时间窗: Postoperative first 24 hours

Opioid consumption postroperative period

次要结局

  • Visual Analog Pain Score(Postoperative first 24 hours)

研究者

发起方
Erzurum Regional Training & Research Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Omer Doymus

Medical Doctor

Erzurum Regional Training & Research Hospital

研究点 (1)

Loading locations...

相似试验